Doctors are studying the use of an older cholesterol drug to reduce PFAS more quickly from the body. MAINE, Maine — Maine is funding blood tests for more than 600 Maine families whose properties were contaminated by forever chemicals. PFAS chemicals can …

A clinical pharmacist has issued an alert for anyone taking with these eight common conditions this Halloween This article contains affiliate links, we will receive a commission on any sales we generate from it. Learn more Certain ingredients in common …

DOXA Platform Expansion Strengthens Cognitive, Arousal, and Neuroprotective Programs Supported by Solid Cash Position and Strategic Funding Outlook ZURICH, Oct. 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP)(Nasdaq: NLSPW) (" …

Samantha Leathers and Michael D. Carroll 03:49 ET, 30 Oct 2025 Halloween often opens a buffet of sweets and treats(Image: GETTY) Halloween might deliver plenty of candy - but these goodies could create serious health hazards, and it has nothing to do with …

Certain ingredients in common Halloween sweets may impact the effectiveness and severity of your medication Halloween may be great for bringing us lots of sweets - but these treats could pose significant health risks, and it's nothing to do with sugar …

Halloween might offer a wealth of sweet treats, but certain sweets could present serious health dangers that have nothing to do with their sugar levels. Combining certain confectionery with particular medicines could trigger unforeseen complications - …

Presented at the 2025 International Congress of Parkinson’s Disease and Movement Disorders (MDS), a long-term, post-hoc analysis of a previous completed phase 3 study found that the efficacy of apomorphine sublingual film (SL-APO; Kynmobi; Sunovion) did …

BETHESDA, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

ADAS-Cog13 difference −12.78 (P < 0.0001) with oral blarcamesine treatment compared to ADNI control group at Week 144 77.4 Weeks (17.8 Months) ‘time saved’ with oral blarcamesine compared to ADNI Restoring impaired Autophagy − preceding amyloid-beta and …

The activation and deactivation of apoptosis is a promising field of research in basic biomedical research. The team led by Prof. Franz Hagn from the Chair of Structural Membrane Biochemistry at the TUM School of Natural Sciences has now discovered a new …